Previous Close | 33.84 |
Open | 33.60 |
Bid | 34.52 x 200 |
Ask | 34.64 x 100 |
Day's Range | 33.60 - 35.04 |
52 Week Range | 11.33 - 40.40 |
Volume | |
Avg. Volume | 777,565 |
Market Cap | 1.296B |
Beta (5Y Monthly) | 1.07 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
The average of price targets set by Wall Street analysts indicates a potential upside of 37.9% in Tarsus Pharmaceuticals, Inc. (TARS). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Tarsus Pharmaceuticals, Inc. ( NASDAQ:TARS ) defied analyst predictions to release its full-year results, which were...
Tarsus Pharmaceuticals, Inc. ( NASDAQ:TARS ) shareholders will have a reason to smile today, with the analysts making...